ArticleEuropean journal of nuclear medicine and molecular imaging2020

Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [

Marco M E Vogel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.